These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 11735347)
1. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. McGee Sanftner LH; Abel H; Hauswirth WW; Flannery JG Mol Ther; 2001 Dec; 4(6):622-9. PubMed ID: 11735347 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor. Wu WC; Lai CC; Chen SL; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3480-8. PubMed ID: 12407159 [TBL] [Abstract][Full Text] [Related]
3. Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18. Green ES; Rendahl KG; Zhou S; Ladner M; Coyne M; Srivastava R; Manning WC; Flannery JG Mol Ther; 2001 Apr; 3(4):507-15. PubMed ID: 11319911 [TBL] [Abstract][Full Text] [Related]
4. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Lau D; McGee LH; Zhou S; Rendahl KG; Manning WC; Escobedo JA; Flannery JG Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3622-33. PubMed ID: 11006261 [TBL] [Abstract][Full Text] [Related]
5. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883 [TBL] [Abstract][Full Text] [Related]
6. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease. Mandel RJ; Snyder RO; Leff SE Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205 [TBL] [Abstract][Full Text] [Related]
7. Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Frasson M; Picaud S; Léveillard T; Simonutti M; Mohand-Said S; Dreyfus H; Hicks D; Sabel J Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2724-34. PubMed ID: 10509671 [TBL] [Abstract][Full Text] [Related]
8. AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa. Dalkara D; Kolstad KD; Guerin KI; Hoffmann NV; Visel M; Klimczak RR; Schaffer DV; Flannery JG Mol Ther; 2011 Sep; 19(9):1602-8. PubMed ID: 21522134 [TBL] [Abstract][Full Text] [Related]
10. GDNF gene therapy attenuates retinal ischemic injuries in rats. Wu WC; Lai CC; Chen SL; Sun MH; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP Mol Vis; 2004 Feb; 10():93-102. PubMed ID: 14961006 [TBL] [Abstract][Full Text] [Related]
11. Ex vivo gene therapy using intravitreal injection of GDNF-secreting mouse embryonic stem cells in a rat model of retinal degeneration. Gregory-Evans K; Chang F; Hodges MD; Gregory-Evans CY Mol Vis; 2009 May; 15():962-73. PubMed ID: 19461934 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190 [TBL] [Abstract][Full Text] [Related]
13. In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration. Buch PK; MacLaren RE; Durán Y; Balaggan KS; MacNeil A; Schlichtenbrede FC; Smith AJ; Ali RR Mol Ther; 2006 Nov; 14(5):700-9. PubMed ID: 16872907 [TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis. Keir SD; Xiao X; Li J; Kennedy PG J Neurovirol; 2001 Oct; 7(5):437-46. PubMed ID: 11582516 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa. Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073 [TBL] [Abstract][Full Text] [Related]
16. A diffusible factor from normal retinal cells promotes rod photoreceptor survival in an in vitro model of retinitis pigmentosa. Streichert LC; Birnbach CD; Reh TA J Neurobiol; 1999 Jun; 39(4):475-90. PubMed ID: 10380070 [TBL] [Abstract][Full Text] [Related]
17. Long-term safety of GDNF gene delivery in the retina. Wu WC; Lai CC; Chen SL; Sun MH; Xiao X; Chen TL; Lin KK; Kuo SW; Tsao YP Curr Eye Res; 2005 Aug; 30(8):715-22. PubMed ID: 16109652 [TBL] [Abstract][Full Text] [Related]
18. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Sarra GM; Stephens C; de Alwis M; Bainbridge JW; Smith AJ; Thrasher AJ; Ali RR Hum Mol Genet; 2001 Oct; 10(21):2353-61. PubMed ID: 11689482 [TBL] [Abstract][Full Text] [Related]
19. Long-term expression of glial cell line-derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa. Ohnaka M; Miki K; Gong YY; Stevens R; Iwase T; Hackett SF; Campochiaro PA J Neurochem; 2012 Sep; 122(5):1047-53. PubMed ID: 22726126 [TBL] [Abstract][Full Text] [Related]
20. Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage. Allocca M; Di Vicino U; Petrillo M; Carlomagno F; Domenici L; Auricchio A Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5199-206. PubMed ID: 17962474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]